Financials
- Market Capitalization 15.12 M
- Employee 7
- Founded 2004
- CEO N/A
- Website www.lexariabioscience.com
- Headquarter Nevada, United States
- FIGI BBG000JQHT18
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.34
Rapporto prezzo/fatturato
22.59
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 4700 | HIND Vyome Holdings, Inc. - Common Stock | 2.22 USD | -0.89% | +1.83% | +2.30% | -84.43% | 15.58 M USD | ||
| 4704 | HOWL Werewolf Therapeutics, Inc. - Common Stock | 0.33 USD | -2.94% | +6.45% | -13.16% | -74.62% | 16.04 M USD | ||
| 4715 | CTXR Citius Pharmaceuticals, Inc. - Common Stock | 0.53 USD | -1.85% | -8.62% | -3.64% | -70.56% | 14.55 M USD | ||
| 4717 | AKTX Akari Therapeutics Plc - American Depositary Shares | 13.02 USD | -2.84% | -3.91% | -3.20% | +1072.97% | 14.90 M USD |